Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps may help stroke patients see the whole picture

NCT ID NCT07580066

Knowledge-focused Sponsor: Luzerner Kantonsspital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a gentle magnetic pulse called cTBS can improve attention in people who, after a stroke, ignore one side of their surroundings. Sixty adults with right-brain stroke and left-sided neglect will receive real or fake stimulation to the cerebellum or brain's attention center. Researchers will track eye movements and brain activity to see if the cerebellum plays a key role in recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
continuous theta burst stimulation (cTBS) using a magnetic coil
What this could lead to
If it works, this could point toward a new non-invasive treatment to help stroke survivors with neglect pay better attention to their surroundings.
What could go wrong
This is a small, early-stage study (60 people) that is not yet recruiting. It tests a temporary effect, not a cure, and may not lead to lasting improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Apr 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * First-ever, subacute right hemispheric stroke * Left-sided visual neglect defined by MGP \> 1.333° * Age ≥18 years * Normal or corrected-to-normal visual acuity * MRI compatibility (MRI-based neuronavigation for cTBS) * Capacity to consent and ability to follow study procedures Exclusion Criteria: * Cerebellar lesion * History of epilepsy * Metallic implants in the head region * Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) * Co-morbidities including: neurological, degenerative or major psychiatric disorder (other than index stroke), alcohol or drug abuse, severe liver or kidney disease, and active malignant tumor disease * Pregnancy * Enrolment in an ongoing clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemispatial neglect are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

perceptual disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemispatial neglect Stroke Visual neglect

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Klinik für Neurologie und Neurorehabilitation

    Lucerne, Canton of Lucerne, 6004, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.